Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Warren Fiskus

23PUBLICATIONS
73CO-AUTHORS
Molecular medicineMedical molecular engineering of nucleic acids and proteinsEpigenetics (incl. genome methylation and epigenomics)Mechatronics hardware design and architectureRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

Sort by Publication Date:
|Mar 12, 2026
Correction: BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML.

Christine E Birdwell, Warren Fiskus, Christopher P Mill

|Feb 24, 2026
Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.

Warren Fiskus, Christopher P Mill, Ghayas C Issa

|Jan 19, 2026
Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML.

Warren Fiskus, Christopher P Mill, Jessica Piel

|Dec 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML.

Christine E Birdwell, Warren Fiskus, Christopher P Mill

|Aug 19, 2025
Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms in blastic phase.

Warren Fiskus, Lucia Masarova, Christopher P Mill

|May 21, 2025
Correction: Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1.

Warren Fiskus, Christopher P Mill, Christine Birdwell

Pageof 4

Frequent Collaborators

17 joint publications

Courtney DiNardo

17 joint publications

Kapil N Bhalla

15 joint publications

Naval G Daver

14 joint publications

Tapan M Kadia

12 joint publications

Christopher P Mill

10 joint publications

Sanam Loghavi

9 joint publications

Koji Sasaki

9 joint publications

Joseph D Khoury

9 joint publications

Koichi Takahashi

8 joint publications

Kaberi Das

Frequent Collaborators

17 joint publications

Courtney DiNardo

17 joint publications

Kapil N Bhalla

15 joint publications

Naval G Daver

14 joint publications

Tapan M Kadia

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

1.0K
Eukaryotic Transcription Inhibitors
01:52

Eukaryotic Transcription Inhibitors

10.9K
See more related videos

Top Related Videos

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors
04:36

Comet Assay to Quantify DNA Damage in FLT3 Mutant-expressing 32D Cells after Exposure to Type I and Type II FLT3 Inhibitors

Published on : Oct 17, 2025

1.0K
Eukaryotic Transcription Inhibitors
01:52

Eukaryotic Transcription Inhibitors

10.9K
See more related videos